Hailey Choi, PharmD, BCACP, CDCES
Articles by Hailey Choi, PharmD, BCACP, CDCES

This case series describes 2 instances of cutaneous sensory disturbance during semaglutide therapy in patients without diabetes and discusses possible mechanisms as hypotheses requiring further investigation.

Insulin Deprescribing Utilizing Continuous Glucose Monitoring With Low-Dose Tirzepatide
ByYoungseon Kim, MS, BS, PharmD Candidate,Hailey Choi, PharmD, BCACP, CDCES,Jennifer Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP Rapid insulin discontinuation occurred with tirzepatide 2.5 mg weekly in long-standing type 2 diabetes, demonstrating a low-dose responder phenotype and pharmacist-led CGM-guided deprescribing.

This case report highlights pharmacists’ collaborative role in optimizing care transitions and diabetes management for a patient newly diagnosed with latent autoimmune diabetes in adults.